Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,148 | 179,894 | 92,933 | 102,304 | 298,887 |
| Marketable Securities | 62,822 | 131,106 | 124,575 | 59,374 | 15,876 |
| Receivables | 305,628 | 129,185 | 51,093 | N/A | 1,389 |
| Inventories | 125,586 | 110,458 | 39,823 | N/A | N/A |
| Other current assets | 57,580 | 15,716 | 9,519 | 2,359 | 2,884 |
| TOTAL | $630,764 | $566,359 | $317,943 | $168,274 | $330,965 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 307 | 600 |
| Investments And Advances | 59,136 | 808 | 0 | 12,404 | 35,533 |
| Intangibles | 0 | 0 | 0 | 799 | 799 |
| Other Non-Current Assets | 373,353 | 10,523 | 11,644 | 11,788 | 11,732 |
| TOTAL | $432,489 | $11,331 | $11,644 | $25,298 | $48,664 |
| Total Assets | $1,063,253 | $577,690 | $329,587 | $193,572 | $379,629 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 975 |
| Accounts payable and accrued liabilities | 107,508 | 58,296 | 38,471 | 42,019 | 51,294 |
| Accrued Expenses | 21,850 | 15,185 | 12,172 | 8,432 | 10,166 |
| Other current liabilities | 2,124 | 4,627 | 1,479 | 1,169 | 1,512 |
| TOTAL | $153,760 | $90,679 | $53,720 | $53,201 | $65,384 |
| Non-Current Liabilities | |||||
| Long Term Debt | 245,645 | 244,429 | 100,118 | 71,135 | 66,788 |
| Deferred Revenues | 21,234 | 11,414 | 152 | N/A | N/A |
| Other Non-Current Liabilities | 7,021 | 8,133 | 9,231 | 10,344 | 9,847 |
| TOTAL | $261,473 | $264,647 | $115,365 | $81,784 | $77,092 |
| Total Liabilities | $415,233 | $355,326 | $169,085 | $134,985 | $142,476 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 159,688 | 157,071 | 154,421 | 146,363 | 142,817 |
| Common Shares | 159 | 156 | 151 | 146 | 143 |
| Retained earnings | -1,082,015 | -1,529,194 | -1,552,577 | -1,527,033 | -1,328,698 |
| Other shareholders' equity | -234 | 6 | -234 | -234 | -234 |
| TOTAL | $648,020 | $222,364 | $160,502 | $58,587 | $237,153 |
| Total Liabilities And Equity | $1,063,253 | $577,690 | $329,587 | $193,572 | $379,629 |